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Endometriosis is a condition wherein an ectopic layer of endometrial tissue arises in an extra-uterine location,
often eﬀecting signiﬁcant pelvic pain and infertility. While very uncommon, there have been reported cases of
endometriosis undergoing malignant transformation, frequently involving the ovaries and seldom in extra-gonadal regions. We recount a case depicting a 63 year-old woman who presented with an apparent inguinal hernia
in 2017; she was ultimately diagnosed with a pelvic side wall clear cell carcinoma and attendant metastatic
disease to the medial groin, which emanated from endometriosis. Malignant transformation of endometriosis
identiﬁed in the pelvic side wall is a very rare ﬁnding. Nevertheless, oncologists should maintain a high index of
suspicion in patients with a history of endometriosis or pelvic surgery.

1. Introduction

2. Case report

Endometriosis is characterized by the presence of ectopic endometrial tissue. The condition, albeit benign, is often painful and a
source of infertility in nearly 10–15% of reproductive-aged women
(Kavoussi et al., 2016). Endometriosis originates from metaplasia of the
coelomic epithelium and has the potential to inﬁltrate distant areas via
hematogenous and lymphatic dissemination (Su et al., 2004).
Endometriosis has been identiﬁed in the ovaries, pelvis, cervix, labia
and vagina (Agarwal & Subramanian, 2010); alternatively, uncommon
implantation sites include the lung, bladder and within abdominal
surgery scars (Acién & Velasco, 2013; Bodner et al., 2003). In very rare
cases, the disease undergoes malignant transformation, with documented rates approximating 0.3% to 1.0% (Matter et al., 2003; Debus &
Schuhmacher, 2001). When this neoplastic process arises, the disease
typically is comprised of endometrioid or clear cell histology (Ruiz
et al., 2015; Bats et al., 2008).
Endometriosis has been described in patients with a history of gynecologic surgery, namely following a caesarean section (Horton et al.,
2008). Nevertheless, it is quite unusual to encounter a carcinoma originating from endometriosis in the abdominal wall (Marques et al.,
2017; Taburiaux et al., 2015), let alone the pelvic side wall. Herein, we
review a patient with clear cell carcinoma of the pelvic side wall,
stemming from endometriosis.

A 63 year-old (gravida 1, para 1) woman initially presented with a
suspected left inguinal hernia in May 2017; The patient's medical history was signiﬁcant for hypertension and hypercholesterolemia. The
initial herniorrhaphy was performed by a general surgeon who aborted
the procedure when he ascertained that the condition was not an inguinal hernia but instead, a malignant condition. During the attempt at
intraoperative repair, a necrotic, cancerous mass was encountered.
Following a review of histologic and imaging data, the lesion was
presumed to be ovarian cancer. The patient's preoperative CA-125 was
470 U/mL; she then commenced with neoadjuvant intravenous chemotherapy encompassing paclitaxel (80 mg/m2) on days 1, 8, and 15 of
a 21-day cycle and carboplatin (AUC 6) on day 1.
After the completion of two cycles of chemotherapy, the patient was
taken to the Operating Room and underwent an exploratory laparotomy, total abdominal hysterectomy and bilateral salpingo-oophorectomy, total omentectomy, bilateral pelvic lymph node dissection,
bilateral inguinal lymph node dissection, radical dissection of the left
inguinal ligament with radical tumor debulking and mesh reconstruction.
During an examination of the abdomen and pelvis, a 12 × 10 cm
cystic and solid left inguinal mass was identiﬁed, which extended
through the femoral canal into the abdominal cavity (Fig. 1). The entire
neoplasm was retroperitoneal, with visible, gross tumor at the distal
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this procedure was repeated on the contralateral side. Subsequently, a
biologic mesh was inserted into the left pelvis, which was secured with
2–0 Vicryl and Tisseel. The right groin mass was completely excised;
The patient tolerated the procedure well and was admitted to the
Recovery Room in stable condition.
The ﬁnal pathology revealed Stage IVB clear cell carcinoma arising
from endometriosis with a synchronous but apparently unrelated stage
IA endometrial adenocarcinoma (Fig. 2a–d). There were also 5 pelvic
lymph nodes positive for malignancy. The disease was conﬁned to the
retroperitoneal/inguinal mass, bilateral inguinal nodes, and left pelvic
lymph nodes. The uterus, cervix, tubes, ovaries, and right pelvic nodes
were normal. Following a molecular biomarker evaluation, her tumor
was determined to be MSI stable, eﬀectively precluding Lynch syndrome. Postoperatively, the patient was slated for radiotherapy and
completion of her chemotherapy regimen.
3. Conclusions

Fig. 1. Large complex solid and cystic mass that is arising from the left hemipelvic sidewall, and extending to the inguinal region and skin surface.

Endometriosis undergoing malignant transformation is an extremely
unusual ﬁnding. Sampson attributed this process to the disease's
proximity to the neoplasm, exclusion of an additional primary site of
malignancy, and the histologic appearance of endometrial stroma
contiguous with epithelial glands (Debus & Schuhmacher, 2001;
Sampson, 1925). Additionally, prolonged exposure to unopposed estrogen has been implicated (Agarwal & Subramanian, 2010; Debus &
Schuhmacher, 2001).
When endometriosis transitions to a malignant pathology, the ovary
is commonly involved (Agarwal & Subramanian, 2010). Conversely,
abdominal wall carcinoma arising from endometriosis is exceedingly
uncommon, with only 27 cases documented since 2014 (Taburiaux
et al., 2015). Carcinoma of the pelvic side wall originating from endometriosis is seemingly more atypical, as we were only able to identify
two patients in the literature with this condition (Leiserowitz et al.,
2003).
In the current study, we review the history of a woman diagnosed
with clear cell carcinoma of the pelvic side wall with metastatic involvement of the medial groin, stemming from endometriosis.
Endometriosis has been identiﬁed as a precursor of clear cell carcinoma, which presumably accounts for the higher incidence of this

iliac vessels and in the medial left inguinal space. There was evidence of
both left pelvic and inguinal lymphadenopathy; furthermore, a pathologically, enlarged right inguinal lymph node, measuring approximately 4 cm, was noted with an absence of pathologic right pelvic and
peri-aortic adenopathy.
The patient's appendix, small and large bowel were all palpably
normal. There was no visible evidence of endometriosis on the uterus or
ovaries. The left ovary was normal and adjacent to the large retroperitoneal pelvic and inguinal mass. The disease was noted to be densely adherent to the external iliac vessels and ﬁxed to the surrounding
tissue, with minimal mobility. An incision was made over the left groin
and approximately 300 mL of dark bloody ﬂuid was aspirated; thereafter, a large, solid and cystic mass in the medial groin incision was
visualized.
The lesion was dissected, mobilized externally and ultimately delivered through the femoral canal into the abdomen. The remaining
tumor and enlarged lymph nodes within the medial inguinal space were
also excised. A left pelvic lymph node dissection, resection of proximal
lymphatic tissue and removal of obturator nodes were also performed;

Fig. 2. a) Representative histologic section of endometrial lesion showing FIGO grade 1 endometrioid-type adenocarcinoma with abundant
squamous morules (H&E; 40×); b) Focus of endometriosis associated with pelvic side wall lesion (H
&E; 40×); c) Area of presumed endometriosis with
hemosiderin deposition in association with clear cell
carcinoma (arrows; H&E; 40×); d) High-power view
of clear cell carcinoma (pelvic side wall lesion) with
variable eosinophilic cytoplasm (eosinophilic variant
of clear cell carcinoma) (H&E; 400×).
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histologic subtype (Taburiaux et al., 2015). The precipitant of the
neoplastic event in the current study remains idiopathic, although one
may conjecture that genetics, immunological or hormonal factors were
contributing factors (Marques et al., 2017). We can ultimately preclude
the inﬂuence of estrogen therapy since the patient did not have a history of taking this medication.
The clinical management of clear cell carcinoma of the pelvic side
wall is indeterminate. Surgical treatment has reportedly been comprised of local resection, total abdominal hysterectomy or salpingooophorectomy (Ijichi et al., 2014). In addition to deﬁnitive surgery, a
regimen of carboplatin and paclitaxel has been considered eﬀective at
treating this malignancy (Marques et al., 2017). Radiotherapy has also
been reportedly beneﬁcial in combination with platinum-based therapy
for the treatment of endometriosis related cases of malignant transformation (Mihailovici et al., 2017); moreover, radiotherapy is potentially
indicated when addressing metastatic disease (Macrie et al., 2014).
Unfortunately, once a patient exhibits disease recurrence, secondary
treatment is ostensibly ineﬀective (Ijichi et al., 2014).
When oncology physicians encounter primary and metastatic lesions in very unusual locations, they should consider the potential for
malignant endometriosis in the diﬀerential diagnosis, especially in patients who have a history of endometriosis, underwent gynecologic
surgery or were previously treated with hormone replacement therapy.
Despite the remote incidence of pelvic side wall carcinoma arising from
endometriosis, we recommend further study evaluating the optimal
method in which to diagnose and manage this complicated disease.
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